Diagnostic ‘omics’ for active tuberculosis

The decision to treat active tuberculosis (TB) is dependent on microbiological tests for the organism or evidence of disease compatible with TB in people with a high demographic risk of exposure. The tuberculin skin test and peripheral blood interferon-γ release assays do not distinguish active TB f...

Descripción completa

Detalles Bibliográficos
Autores principales: Haas, Carolin T., Roe, Jennifer K., Pollara, Gabriele, Mehta, Meera, Noursadeghi, Mahdad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804573/
https://www.ncbi.nlm.nih.gov/pubmed/27005907
http://dx.doi.org/10.1186/s12916-016-0583-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804573/
https://www.ncbi.nlm.nih.gov/pubmed/27005907
http://dx.doi.org/10.1186/s12916-016-0583-9

Ejemplares similares